Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 3;12(11):711–723. doi: 10.14740/jocmr4352

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright 2020, Lan et al.

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Serum TRAb levels in PTM patients higher than Graves’ disease without PTM (GD w/o PTM) patients and normal persons. Comparison of serum TRAb levels was performed between 400 PTM cases and 800 control cases. The control cases included 400 GD w/o PTM cases and 400 normal person cases. Serum TRAb levels (129.151 ± 165.948 IU/L) in PTM group were significantly higher than those (11.163 ± 10.815 IU/L) in GD w/o PTM patients and those (0.383 ± 0.198 IU/L) in normal persons (P < 0.001). The serum TRAb levels (11.163 ± 10.815 IU/L) in GD w/o PTM cases were significantly higher than those (0.383 ± 0.198 IU/L) in normal persons (P < 0.01). PTM: pretibial myxedema; TRAb: TSH receptor antibodies; TSH: thyroid-stimulating hormone.